Is the gut microbiome key to modulating vaccine efficacy?

Expert Review of Vaccines

Volumn 14, Issue 6, 2015, Pages 777-779

  Nakaya, Helder I ^a,b   Bruna Romero, Oscar ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

dysbiosis; immunity; microbiome; systems vaccinology; vaccine efficacy; vaccines

Indexed keywords

VACCINE;

COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; IMMUNOLOGIST; INTESTINE FLORA; NONHUMAN; PRIORITY JOURNAL; REVIEW; TECHNOLOGY; IMMUNOLOGY;

GASTROINTESTINAL MICROBIOME; HUMANS; VACCINES;

EID: 84929306018     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2015.1040395     Document Type: Review

References (16)

1. Didierlaurent A, Simonet M, Sirard JC. Innate and acquired plasticity of the intestinal immune system. Cell Mol Life Sci 2005;62(12):1285-7.
2. Levine MM. Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine. BMC Biol 2010;8:129.
3. Hallander HO, Paniagua M, Espinoza F, et al. Calibrated serological techniques demonstrate significant different serum response rates to an oral killed cholera vaccine between Swedish and Nicaraguan children. Vaccine 2002;21(1-2):138-45.
4. Lopman BA, Pitzer VE, Sarkar R, et al. Understanding reduced rotavirus vaccine efficacy in low socio-economic settings. PLoS One 2012;7(8):e41720.
5. Grassly NC, Jafari H, Bahl S, et al. Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India. J Infect Dis 2009;200(5): 794-801.
6. Humphrey JH. Child undernutrition, tropical enteropathy, toilets, and handwashing. Lancet 2009;374(9694): 1032-5.
7. Kamada N, Seo SU, Chen GY, Nunez G. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 2013;13(5):321-35.
8. Pulendran B, Li S, Nakaya HI. Systems vaccinology. Immunity 2010;33(4):516-29.
9. Querec TD, Akondy RS, Lee EK, et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 2009;10(1): 116-25.
10. Nakaya HI, Wrammert J, Lee EK, et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol 2011; 12(8):786-95.
11. Cullender TC, Chassaing B, Janzon A, et al. Innate and adaptive immunity interact to quench microbiome flagellar motility in the gut. Cell Host Microbe 2013;14(5):571-81.
12. Oh JZ, Ravindran R, Chassaing B, et al. TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination. Immunity 2014; 41(3):478-92.
13. Valdez Y, Brown EM, Finlay BB. Influence of the microbiota on vaccine effectiveness. Trends Immunol 2014;35(11):526-37.
14. Soh SE, Ong DQ, Gerez I, et al. Effect of probiotic supplementation in the first 6 months of life on specific antibody responses to infant Hepatitis B vaccination. Vaccine 2010;28(14):2577-9.
15. Brotman RM, Ravel J, Bavoil PM, et al. Microbiome, sex hormones, and immune responses in the reproductive tract: Challenges for vaccine development against sexually transmitted infections. Vaccine 2014;32(14):1543-52.
16. Biesbroek G, Wang X, Keijser BJ, et al. Seven-valent pneumococcal conjugate vaccine and nasopharyngeal microbiota in healthy children. Emerg Infect Dis 2014; 20(2):201-10.